Oscotec Inc. (KOSDAQ:039200)

South Korea flag South Korea · Delayed Price · Currency is KRW
37,500
+500 (1.35%)
Aug 28, 2025, 3:30 PM KST
1.35%
Market Cap1.42T
Revenue (ttm)43.34B
Net Income (ttm)4.25B
Shares Out38.26M
EPS (ttm)111.32
PE Ratio332.74
Forward PE165.92
Dividendn/a
Ex-Dividend Daten/a
Volume250,793
Average Volume114,042
Open36,750
Previous Close37,000
Day's Range36,550 - 38,250
52-Week Range21,600 - 43,700
Beta1.63
RSI72.14
Earnings DateAug 13, 2025

About Oscotec

Oscotec Inc. operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses. It develops SKI-O-703, a SYK inhibitor that is in Phase 2 clinical trials to treat rheumatoid arthritis and idiopathic thrombocytopenic purpura; SKI-G-801, a selective FLT3/AXL inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia, as well as other solid tumors; and lazertinib, a 3rd generation EGFR inhibitor that is in Phase 3 clinical trials... [Read more]

Sector Healthcare
Founded 1998
Employees 51
Stock Exchange KOSDAQ
Ticker Symbol 039200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.